Are there mood neutral cholesterol drugs like lipitor?

Are there mood neutral cholesterol drugs like Lipitor?
Lipitor is a statin that lowers LDL cholesterol by blocking HMG-CoA reductase. Some patients report mood changes such as irritability or low mood while taking it, but controlled studies show these effects are uncommon and usually reversible after stopping the drug.

Which statins are least likely to affect mood?
Atorvastatin (Lipitor) and rosuvastatin (Crestor) are the most studied statins and show the lowest rates of reported mood issues. Pravastatin and pitavastatin cross the blood-brain barrier less readily, so some clinicians switch patients to these when mood symptoms appear, though direct head-to-head mood data are limited.

Do non-statin cholesterol drugs avoid mood side effects?
Ezetimibe (Zetia) blocks intestinal cholesterol absorption and has not been linked to mood changes in large trials. PCSK9 inhibitors such as evolocumab (Repatha) and alirocumab (Praluent) are monoclonal antibodies given by injection; psychiatric side effects were no higher than placebo in their registration studies. Bempedoic acid (Nexletol) works upstream of statins and carries no reported mood signal to date.

How do patients decide between statins and non-statins?
Guidelines still recommend a statin as first-line therapy because of decades of cardiovascular-outcome data. When mood symptoms occur, clinicians typically reduce the statin dose, switch to a different statin, or add ezetimibe or a PCSK9 inhibitor rather than abandon LDL lowering altogether. Regular symptom checks at follow-up visits help catch rare mood effects early.

When will cheaper non-statin options be available?
Ezetimibe is already generic. The first PCSK9 biosimilars are expected after 2025, once the reference-product patents expire. Bempedoic acid’s composition-of-matter patent runs to 2030, but combination tablets with ezetimibe may reach generic status sooner. DrugPatentWatch.com tracks these expiry dates and litigation updates for each product.